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To understand the functions of the kidney, the transcriptome of each part of the
nephron needs to be proﬁled using a highly sensitive and unbiased tool. RNA
sequencing (RNA-seq) has revolutionized transcriptomic research, enabling re-
searchers to deﬁne transcription activity and functions of genomic elements with
unprecedented sensitivity and precision. Recently, RNA-seq for polyadenylated
messenger RNAs [poly(A)0-mRNAs] and classical microdissection were successfully
combined to investigate the transcriptome of glomeruli and 14 different renal tu-
bule segments. A rat kidney is perfused with and incubated in collagenase solution,
and the digested kidney was manually dissected under a stereomicroscope. Indi-
vidual glomeruli and renal tubule segments are identiﬁed by their anatomical and
morphological characteristics and collected in phosphate-buffered saline. Poly(A)0-
tailed mRNAs are released from cell lysate, captured by oligo-dT primers, and made
into complementary DNAs (cDNAs) using a highly sensitive reverse transcription
method. These cDNAs are sheared by sonication and prepared into adapter-ligated
cDNA libraries for Illumina sequencing. Nucleotide sequences reported from the
sequencing reaction are mapped to the rat reference genome for gene expression
analysis. These RNA-seq transcriptomic data were highly consistent with prior
knowledge of gene expression along the nephron. The gene expression data ob-
tained in this work are available as a public Web page (https://helixweb.nih.gov/
ESBL/Database/NephronRNAseq/) and can be used to explore the transcriptomic
landscape of the nephron.
Copyright © 2015. The Korean Society of Nephrology. Published by Elsevier Ltd. This
is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Proﬁling all the transcripts expressed in the glomerulus and
each renal tubule segment will greatly advance our under-
standing of the functions and pathophysiology of the kidney.
This task requires a precise, unbiased, and high-throughputInnovation, Biomedical
ospital, 28 Yongon-dong,
iety of Nephrology. Published
y-nc-nd/4.0/).transcriptomic method that enables researchers to create a
catalog of all the RNA species and accurately measure their
quantities in a cell.
However, gene expression proﬁling methods that have been
used in renal transcriptomics such as microarrays [1,2] or
Sanger sequencing of complementary DNAs (cDNAs) [3e5]
suffer from low sensitivity and high false positivity. The util-
ity of microarrays is limited by the requirement of prior
knowledge of genes expressed in a cell and by a narrow range of
dynamic expression due to signal saturation. Sanger
sequencing of cDNAs is low throughput and not sensitive
enough to detect lowly expressed transcripts.by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
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sequencing (NGS) technologies to proﬁle the whole tran-
scriptome in a massive parallel manner [6]. In this method,
RNAs of interest [i.e., messenger RNAs (mRNAs), microRNAs, or
other noncoding RNAs] are converted into adapter-ligated
cDNAs and sequenced in a parallel manner, generating
massive amount of short DNA sequences (typically 35e100
base pairs) [6]. These nucleotide sequences (commonly called
reads) are either mapped to a reference genome or assembled
to generate a de novo transcriptome. Reads mapped to the
reference genome can be visualized on a genome browser to
explore transcriptional activity across the genome or can be
counted to quantify the expression level of each transcript.
Comparedwithmicroarrays or Sanger sequencing, RNA-seq has
many advantages, including higher sensitivity (requiring lower
amount of RNAs), low false positivity (no background signals
originating from cross-hybridization), unlimited range of dy-
namic expression (no signal saturation), and capability to
process many samples in high-throughput settings (many
samples can be multiplexed and sequenced in parallel).
Recently, RNA-seq transcriptomic data for glomeruli and 14
different renal tubule segments collected from rat kidneys have
been published [7]. This review discusses the technical aspects
of RNA-seq proﬁling of the nephron, focusing on how RNA-seq
and classical microdissection can be combined to proﬁle the
transcriptomes of the rat nephron. This review does not intend
to provide an in-depth review of the NGS technologies. Readers
are referred to excellent reviews on the principles of NGS [8,9].
For more general information on RNA-seq, the author would
like to recommend a well-curated online Web site available at
http://rnaseq.uoregon.edu/.
Microdissection of renal tubule segments
Collagenase-assistedmanual microdissection of renal tubule
segments, ﬁrst reported by Burg et al in 1966 [10], has been
successfully used in renal physiology for more than 4 decades.
This method expanded the scope of renal research to glomeruli
and tubule segments that had not been accessible by micro-
puncture. To collect glomeruli and renal tubule segments for
RNA-seq proﬁling, a protocol previously published in the article
byWright et al [11] was used with minor modiﬁcations. A male
Sprague Dawley rat weighing 150e200 g is killed by decapi-
tation (Animal Study Protocol No. H-0110R2, approved by the
Animal Care and Use Committee, National Heart, Lung, and
Blood Institute). After a midline incision of the abdominal wall,
the left renal artery is selected by introducing a ligature in the
aorta between the left and renal arteries. Then, a thin plastic
catheter is introduced through a slit made on the wall of the
aorta below the level of the left renal artery, and through this
catheter, the left kidney is perfused with 10 mL of ice-cold,
bicarbonate-free dissecting solution (NaCl 135 mmol/L;
Na2HPO41mmol/L; Na2SO41.2 mmol/L; MgSO41.2 mmol/L; KCl
5 mmol/L; CaCl2 2 mmol/L; glucose 5.5 mmol/L; and HEPES
5mmol/L, adjusted to pH 7.4), followed by 10mL of collagenase
solution [1 mg/mL of collagenase B (puriﬁed from Clostridium
histolyticum, Roche Diagnostics, Indianapolis, IN, USA) and 1
mg/mL of bovine serum albumin (MP Biomedicals, Santa Ana,
CA, USA) in the dissecting solution] warmed to 37C. Before use,
the dissecting solution in which collagenase and bovine serum
albumin are to be dissolved is usually bubbled with 100% O2 for
10minutes tomitigate hypoxia. It is crucial that the blood in theleft kidney is completely removed by the initial perfusion with
the dissecting solution because protease inhibitors in the
plasma prevent collagenase from acting on the kidney.
Although some renal tubule segments (e.g., the cortical col-
lecting duct) can be dissected without collagenase digestion,
most parts of the nephron cannot be dissected if the kidney is
not properly digested. To facilitate the perfusion process, the
wall of the inferior vena cava needs to be cut so that the blood
and solution returning from the left kidney via the left renal
vein can easily exit the circulation. After the perfusion with the
collagenase solution, the left kidney is removed and cut into ~1
mm3 cubes, put into the same collagenase solution, and incu-
bated in a chamber ﬁlled with O2 at 37C for 30e90 minutes.
The concentration of collagenase and the duration of incuba-
tion need to be adjusted, depending on which tissue
compartment is going to be dissected. The cortex can be
digested in 1% collagenase for 30 minutes. The outer and inner
medullas require a higher collagenase concentration and longer
duration (1% and 45 minutes for the outer medulla; 3% and up
to 90 minutes for the inner medulla), along with hyaluronidase
of the same concentration as collagenase. Even with a higher
concentration of collagenase, digestion of the inner medulla
was successful only once in every 3 or 4 experiments. A thor-
ough pretreatment of the dissecting solution and other appa-
ratuses to inactivate ribonuclease is generally not needed,
although general precautions used in RNA works (i.e., wearing
gloves, using ribonuclease-inactivating products) need to be
followed. This is probably because the content of ribonuclease
is not high in the kidney compared with other organs such as
the spleen or the pancreas.
After digestion, the tissue chunks are taken out of the
collagenase solution, washed twice in ice-cold dissecting so-
lution to end digestion process, and put in a glass dish con-
taining ice-cold dissecting solution. This dish is then brought
under a stereomicroscope for microdissection. To minimize
tissue degradation, the digested kidney tissue needs to be
maintained at a cool temperature, ideally at 4C. It is generally
recommended to use a stereomicroscope that has a coolant-
circulating system attached to the bottom of the stage of the
microscope. If the glass dish containing the digested tissue is
maintained at 4C, a microdissection session can be extended
up to 4 hours with minimal tissue degradation. For optimal
identiﬁcation of tubule segments, it is better to have the light
source for the stereomicroscope below the object stage.
The digested kidney tissue is examined using Dumont
No. 5 forceps (https://www.dumonttweezers.com/Tweezer/
Tweezer/469). Before use, the tips of the tweezers need to be
sharpened and polished with a piece of sandpaper so that the
tweezers can easily grab andmanipulate tubule segments and a
dissected tubule segment or other irrelevant tissue does not
stick to the surface of the tweezer tips. The degree of tissue
digestion can be assessed by trying to grab and separate tissue
chunk using tweezers. If it is too difﬁcult to separate tubules
from surrounding tissue, the tissue chunks can be transferred
back to the collagenase solution for more digestion (up to 5e10
minutes).
Identifying individual renal tubule segments requires
working knowledge of renal anatomy. Through practice, the
dissector becomes more and more familiar with the
morphology and locations of individual renal tubule segments.
The anatomical and morphological characteristics of renal tu-
bule segments were described in detail in the article by Wright
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important when tubules with similar looks exist in more than 1
tissue compartment (e.g., S1, S2, and S3 segments of the
proximal tubule: S1 is connected to a glomerulus; S2 exists in
the medullary ray; and S3 exists in the outer medulla and
transitions to the thin descending limb).
With tissue manipulation and microdissection, the visual
ﬁeld easily becomes cluttered with tissue debris and ﬂoating
tubules. Therefore, it is critically important that the collected
glomeruli and tubule segments be washed in 1 phosphate-
buffered saline (PBS) before they are ﬁnally collected for RNA-
seq. This step minimizes contamination from other tubules
and tissue debris. A new glass dish containing 1 PBS is pre-
pared on a separate stereomicroscope, and the microdissected
glomeruli or tubule segments are collected using a long 10-mL
pipette tip and transferred to the PBS dish. Although thin glass
tubes were used in the original description of this step [11],
pipette tips are much easier to manipulate.
After washing 2 times, the dissected tubules are collected in
2 mL of 1 PBS using a pipette tip and put into a 0.5-mL poly-
merase chain reaction (PCR) tube. It is important to use as small
volume of PBS as possible to collect the dissected tubules so
that primers, deoxyribonucleotide triphosphates (dNTPs), and
enzymes used in the reverse transcription are not diluted.Figure 1. The workﬂow of the RNA-seq proﬁling of the nephron transcriptom
prepared into adapter-ligated cDNA libraries through reverse transcription an
sequences.
cDNAs, complementary DNAs; poly(A)0-mRNA, polyadenylated messenger RNAConstruction of RNA-seq libraries
The overallworkﬂow for the construction of cDNA libraries for
RNA-seq of microdissected renal tubule segments is shown in
Fig.1. Themicrodissected renal tubule segments are lysed inmild
cell lysis condition, and mRNAs are released from the cell lysate.
Cell lysis
An experienced dissector can collect 1e4 mm (typically
500e2,000 cells) of renal tubule segments within 2e4 hours.
Provided that a renal tubular epithelial cell contains ~1 pg of
total RNAs, there are likely less than 1 ng of total RNAs in the
collected sample. Because a conventional RNA-seq method that
involves RNA fragmentation and reverse transcription with
random hexamer primers (e.g., Illumina TruSeq protocol) re-
quires a minimum of 100 ng of total RNAs as starting material, a
highly sensitive method capable of creating cDNAs from a very
small amount of total RNAs is needed for RNA-seq of renal
tubule segments. For this work, the author used a modiﬁed
version of the single-cell RNA-seq method that was originally
developed for transcriptomic proﬁling of human oocytes [12].
To lyse the dissected tubules and release mRNAs, 20 mL of
mild cell lysis buffer [0.9 PCR Buffer II without MgCl2 (Lifee. Poly(A)0-mRNAs released frommicrodissected renal tubule segments are
d ampliﬁcation. Illumina sequencing generates 50-bp paired-end FASTQ
; RNA-seq, RNA sequencing.
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Technologies); 0.45% Nonidet P-40 (Sigma-Aldrich, St. Louis,
MO, USA); 4.5mmol/L dithiothreitol (Life Technologies); 0.18 U/
mL SUPERase-In (Ambion, Grand Island, NY, USA); 0.36 U/
mL RNase inhibitor (Ambion); 12.5nM UP1 primer (50-ATATG-
GATCCGGCGCGCCGTCGACTTTTTTTTTTTTTTTTTTTTTTTT-30);
dNTP mix (0.045 mmol/L each); and nuclease-free water] is
added to the PBS containing dissected tubules and mixed well
using a pipette. This mixture is spun down at 7,500 g at 4C for
30 seconds, heated at 70C for 90 seconds to release mRNAs,
and then spun down again at 7,500 g at 4C for 30 seconds.
Then, 0.5 mL of the cell lysate is taken and added to a new 0.5-mL
PCR tube containing 4 mL of the same cell lysis buffer to make a
total of 4.5 mL. The last step minimizes the dilution of the re-
agents for reverse transcription by PBS. This cell lysate should
be used immediately for the ﬁrst-strand synthesis.
Alternatively, total RNAs can be isolated from micro-
dissected tubule segments using silica membrane columns.
When columns are used, RNAs should be eluted in as small
volume (~5 mL) as possible. An advantage of column-based RNA
isolation over direct cell lysis is that RNAs can be stored in a
e70C freezer for future work.
Reverse transcription and ampliﬁcation
The method for cDNA synthesis used in the nephron RNA-
seq is shown in Fig. 2. This homopolymer-tailing method
uses a pair of universal oligo-dT primers and poly(A)0-tailing
of 50-ends to allow for PCR ampliﬁcation. Despite several
shortcomings such as limited coverage of proximal exons,
bias toward 30-end, and loss of strand information, this
method is sensitive enough to reliably amplify mRNAs from
total RNAs as small as 20 pg [12]. The ﬁrst-strand synthesis is
started by adding 0.5 mL of reverse transcriptase mix [13.2 U/
mL SuperScript III reverse transcriptase (Life Technologies);
0.4 U/mL RNase inhibitor (Ambion); and 0.07 U T4 gene 32
protein (Roche Diagnostics)] to 4.5 mL of the cell lysate to
make 5 mL. If the total RNAs were isolated using silicaFigure 2. The method for reverse transcription used in the RNA-seq proﬁling
primer that has a universal nucleotide sequence (UP1). After the ﬁrst-strand syn
RNA template is degraded. The second-strand synthesis is initiated by adding
merase [TaKaRa Ex Taq HS DNA polymerase (Clontech)]. The resulting cDNAs are
for 18e20 cycles, then using NH2-modiﬁed primers for 9e12 cycles.
cDNAs, complementary DNAs; mRNA, messenger RNA; RNA-seq, RNA sequencimembrane columns, 0.5e1 mL of the total RNA is added to
4e4.5 mL of the same cell lysis buffer (see the previous sec-
tion) to make the total volume of 4.5 mL, and then 0.5 mL of
the reverse transcriptase mix is added. Because the cell lysis
step is not needed, NP-40 can be replaced with the same
volume of nuclease-free water. The UP1 primers in the cell
lysate capture poly(A)0-mRNAs.
All the steps following the ﬁrst-strand synthesis leading to
cDNA ampliﬁcation are identical to the previously published
protocol [7,12]. After removing excess primers, a poly(A)0-tail is
added to the 50-end of the DNAeRNA hybrid molecule (the
product of the ﬁrst-strand synthesis) by terminal transferase to
allow for primer annealing in the next step, and the RNA
template is removed by RNase H. Then, the second-strand
synthesis is performed using a second universal primer (UP2,
50-ATATCTCGAGGGCGCGCCGGATCCTTTTTTTTTTTTTTTTTTTTTT
TT-30) annealing to the poly-(A)0 tail added to the 50-end in the
previous step. Finally, this cDNA molecule is ampliﬁed (the
ﬁrst-round PCR, 18e20 cycles) using the same universal
primers (UP1 and UP2) and a high-performance DNA poly-
merase [TaKaRa Ex Taq HS DNA polymerase (Clontech Labora-
tories, Mountain View, CA, USA)].
Once the ﬁrst-round PCR is complete, a quantitative real-
time PCR (qRT-PCR) for a housekeeping gene (e.g., glutaralde-
hyde-3-dehydrogenase, beta-actin) is performed to see if the
reverse transcription and ampliﬁcation are successful. A suc-
cessfully ampliﬁed sample will show an ampliﬁcation curve
that begins to rise before 20e25 cycles of qRT-PCR. If the qRT-
PCR is successful, the cDNAs ampliﬁed in the ﬁrst-round PCR
are further ampliﬁed (the second-round PCR, 9e12 cycles) us-
ing NH2-modiﬁed universal primers [50-NH2-UP1, 50-(NH2)-
ATATGGATCCGGCGCGCCGTCGACTTTTTTTTTTTTTTTTTTTTTTT
T-30; and 50-NH2-UP2, 50-(NH2)-ATATCTCGAGGGCGCGCCG-
GATCCTTTTTTTTTTTTTTTTTTTTTTTT-30]. The purpose of this
switch to NH2-modiﬁed primers is to minimize the amount of
primer sequences appearing in the ﬁnal cDNA libraries. The
total number of PCR rounds should not exceed 32 because
excessive ampliﬁcation likely introduces more PCR errors.of rat renal tubule segments. Poly(A)0-mRNAs are captured by an oligo-dT
thesis, a poly(A)0-tail is added to the 30-end of the ﬁrst DNA strand, and the
a second universal primer (UP2), dNTPs, and a highly effective DNA poly-
ampliﬁed by two rounds of ampliﬁcation, ﬁrst using UP1 and UP2 primers
ng; dNTP, deoxyribonucleotide triphosphate.
Figure 3. The FASTQ format and quality check for FASTQ sequences. An
example of FASTQ format (A). An example of quality assessment for an
Illumina data set (B). In this ﬁgure, quality scores at each nucleotide po-
sition are summarized and shown in bar graphs. The lower and upper
margins of a yellow bar represent 25th and 75th percentile, respectively.
The red line in the middle of each yellow bar is the median value for the
quality scores at each nucleotide.
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To create adapter-ligated cDNAs compatible with Illumina
sequencing, the cDNAs ampliﬁed in the previous step are
sheared into ~200 bp fragments by sonication using a Covaris
S2 system (Covaris Inc., Woburn, MA, USA) and then ligated to
adapters. Before committing many samples to the adapter
ligation process, the condition for sonication needs to be opti-
mized so that the average size of the fragments is around 200
bp. After sonication, the cDNA fragments are cleaned up and
eluted in 50 mL of nuclease-free water. The adapter ligation
process is done on a Mondrian SPþ workstation (NuGen, San
Carlos, CA, USA) using an Ovation Ultralow library prep system
(NuGen). Finally, the adapter-ligated cDNAs are ampliﬁed with
10e18 rounds of PCR and visualized on 2% agarose gel to select
cDNAs within 200e400 bp. The concentration of the ﬁnal cDNA
library is determined using a Qubit ﬂuorometer (Invitrogen,
Grand Island, NY, USA). A good cDNA library will give a con-
centration ranging from 1 to 5 ng/mL.
Using adapters with multiplexed barcodes, cDNA libraries
from multiple samples can be mixed into a single library for
sequencing. The barcodes are 6-nucleotide-long DNA se-
quences incorporated in the stem or arm of the adapter
molecule, and they can be used as identiﬁers for individual li-
braries. Each library is prepared using a barcoded adapter, and
cDNA libraries with different barcodes are mixed in the same
amount (e.g., 10 ng each) so that each library can be sequenced
at the same depth. This multiplexing technique can save
considerable amount of resource by enabling researchers to
obtain sequences frommultiple samples in a single sequencing
run without signiﬁcant loss of depth of sequencing. For
example, 8 barcoded libraries can be mixed into 1 sample and
sequenced to generate ~30 million sequences per each library.
This depth of sequencing is usually good enough for differential
expression analysis.
Next-generation sequencing
The technical details of Illumina sequencing are reviewed in
the article by Metzker [9]. In the Nephron RNA-seq project [7],
the adapter-ligated cDNA libraries were sequenced at the Ge-
nomics Core Facility of the National Heart, Lung, and Blood
Institute using an Illumina HiSeq 2000 platform (Illumina Inc.,
San Diego, CA, USA) to generate 50-bp paired-end reads.
Because it is usually not feasible for a small individual labora-
tory to own and operate an expensive sequencer, adapter-
ligated cDNA libraries are usually sent to a core laboratory or
a company that offers sequencing as a paid service. The choice
between single- and paired-end sequencing depends on the
purpose of the transcriptomic study to be conducted and re-
sources available. Although paired-end sequencing enables
more accurate mapping and thereby generates more informa-
tion on the transcriptome, it takes longer and costs more
money than single-end sequencing does. Paired-end
sequencing is preferred for a deep proﬁling of transcriptome,
whereas single-end sequencing usually sufﬁces when the pri-
mary goal is differential expression analysis of known genes.
Analysis of RNA-seq data
The nucleotide sequences of cDNA libraries are reported in
FASTQ format, “FASTA with quality scores.” Fig. 3A is anexample of a FASTQ sequence reported by an Illumina platform
(Illumina Pipeline version 1.9). A FASTQ ﬁle normally uses 4
lines per sequence. The ﬁrst line begins with a “@” character
and bears information on machine ID, ﬂowcell ID, coordinates
on a ﬂowcell, and a barcode sequence. The second line is the
actual nucleotide sequence. Line 3 begins with a “þ” character
and is optionally followed by the same sequence identiﬁer. Line
4 is ASCII representation of the quality scores for the sequence
in the second line. In Illumina pipeline (since version 1.4), the
quality score of a nucleotide (called Phred score) is determined
by Q ¼ e10  log10p, where p is the probability that the
nucleotide is wrong, and converted to ASCII code by adding 33.
For example, if the quality score for a nucleotide is 50, then the
probability that the nucleotide is wrong is 10e5. Its decimal
ASCII code is 83, which is S.
Before the main analysis, the overall quality of these FASTQ
reads needs to be assessed because inclusion of poor-quality
nucleotides likely leads to erroneous mapping. Fig. 3B is a
snapshot of a bar graph for quality scores at each nucleotide
position. This graph was created using FastQC, a quality
assessment tool available at http://www.bioinformatics.
babraham.ac.uk/projects/fastqc/. Poor-quality nucleotides
with a low-quality score need to be trimmed off to improve
mapping quality. The author used a trimming program Trim-
momatic [13] to inspect each sequence and trim off nucleotides
with quality score lower than 30. If the remaining sequence is
shorter than 35 nucleotides, thewhole sequencewas discarded.
In addition to sequencing-quality scores, other measures of li-
brary quality such as overrepresented sequences, GeC content,
sequence length distribution, or sequence duplication can also
Kidney Res Clin Pract 34 (2015) 219e227224be analyzed using FastQC. A few red ﬂags in this test do not
necessarily mean that the library was poorly sequenced or
prepared. Each red ﬂag needs to be carefully inspected and
judged on whether it is signiﬁcant.
For transcriptomic analysis, the reported RNA-seq reads need
to be mapped to the genome or transcriptome of a target or-
ganism (Fig. 4A). Thismappingprocess is done usingone ofmany
programs dedicated to the analysis of RNA-seq reads. The author
used STAR [14] to map RNA-seq reads to the rat reference
genome (rn5). STAR is capable of precise mapping across
exoneintron junctions and runsmuch faster than othermapping
programs [e.g., Bowtie 2, TopHat2, and Burrows-Wheeler Aligner
(BWA)] but requires a large amount of computer resource (e.g.,
>16 GB of RAM and a multicore central processing unit). The
mapped data are reported in a format called Sequence Align-
ment/Map or Binary Alignment/Map. These ﬁles are eitherFigure 4. Mapping RNA-seq reads to the genome. (A) Paired-end FASTQ sequ
(B) A snapshot of the Integrated Genome Viewer (https://www.broadinstitute.o
microdissected cortical collecting ducts. The thick blue bars (exons) and thin bl
RNA-seq, RNA sequencing.further processed for downstream analysis or loaded onto a
genome browser (Fig. 4B).
The mapped data need to be inspected in several ways to
make sure that the overall library preparation and the mapping
process were successful. First, the overall mapping rate, i.e., the
proportion of reads mapped to the reference genome, should
be higher than 70%. If this mapping rate is low, for example,
<50%, it is mainly because the cDNA library did not contain
sufﬁcient amount of RNAs originating from the collected tu-
bules, suggesting a failure in microdissection and/or cell lysis.
In the nephron RNA-seq project, the author did not include
samples that have the overall mapping rate lower than 65% [7].
Second, the annotated exons (i.e., protein-coding exons) should
be enriched in the mapped data from a good cDNA library (e.g.,
>60% of reads mapped to annotated exons). If exons are not
sufﬁciently enriched in an RNA-seq data set, contaminationences that passed the quality check are mapped to the reference genome.
rg/igv/) shows RNA-seq reads mapping to Aqp2 in a sample prepared from
ue lines (introns) at the bottom represent the Ensembl transcript for Aqp2.
Lee / RNA sequencing of the nephron transcriptome 225from genomic DNA or other sources should be suspected. A
good RNA-seq data set may contain 10e15% of reads mapping
to introns as they likely originate from preprocessed mRNAs or
retained introns. Third, as a sanity check, the mapped data
should be visualized on a genome browser (Fig. 4B). By exam-
ining the expression of several markers or genes of interest on
the genome browser, a researcher can judge whether the
overall process of microdissection, sequencing, and mapping is
successful. The expression of a tubule marker or a gene known
to be expressed in the sample should be consistent with
existing knowledge. For example, water channel aquaporin-2
(Aqp2, NM_012909) should be highly expressed in samples
prepared from the connecting tubule and collecting ducts;
aquaporin-1 in the proximal tubule and descending thin limbs;
and the bumetanide-sensitive NaþeKþe2Cle cotransporter
(Slc12a1, NM_001270617 and NM_001270618) in the thick
ascending limb. In addition, markers of adjacent tubule seg-
ments should be minimally seen in the sample. Fig. 5 is a
snapshot of an RNA-seq data set created from microdissected
cortical thick ascending limb segments, showing that uromo-
dulin (Umod, NM_017082) and Slc12a1 are highly expressed,
whereas the thiazide-sensitive NaþeCle cotransporter (Slc12a3,
NM_019345) and Aqp2 are not expressed at all.Figure 5. RNA-seq of the cortical thick ascending limb transcriptome. The
mapping can be examined by visualizing the mapped data on a genome bro
nephron. RNA-seq data from the cortical thick ascending limb visualized on the
uromodulin (Umod) and the bumetanide-sensitive NaþeKþe2Cle cotransporte
RNA-seq, RNA sequencing; UCSC, University of California, Santa Cruz.Tomeasure gene expression inRNA-seq, the readsmapped to
a transcript or gene are counted and summarized. This counting
process requires a mapped ﬁle in the Sequence Alignment/Map
or Binary Alignment/Map format and an annotation ﬁle for an
organism. The annotation ﬁles are available at Ensembl (http://
ensembl.org) or University of California at Santa Cruz (UCSC)
database (http://genome.ucsc.edu) in the general feature format
(GTF) or browser extensible data (BED) format. With these
annotation databases, counting can be done using a tool such as
htseq-count [15] or BEDTools [16]. Although the expression level
of a gene is obviously proportional to the number of RNA-seq
reads mapped to the gene, this number cannot be directly
used to compare gene expression between 2 different genes or
conditions without normalization. Figs. 6A, B illustrate the 2
most important factors that confound the read count data,
namely the depth of sequencing (i.e., the total number of reads
mapped to genome) and the length of a transcript (i.e., the
number of nucleotides in exons of the transcript). To address
these issues, a normalized measure called the read per kilobase
exon model inmillion mapped reads (RPKM) was introduced to
allow for comparison of gene expression across different genes
and samples [17] (Fig. 6C). When the median RPKM values of
tubule markers were obtained from replicates of 14 differentprecision of microdissection and the quality of library preparation and
wser and by plotting the axial distribution of tubular markers along the
UCSC genome browser (adapted from Lee et al [7]) show high expression of
r (Slc12a1) and no expression of adjacent markers Slc12a3 and Aqp2.
Figure 6. Normalizing RNA-seq read count data against the depth of sequencing and the length of a gene. (A) In this example, Condition 1 has twice
more reads for Gene A than Condition 2. However, Condition 1 also has twice as many mapped reads as Condition 2. If the number of reads mapped to Gene
A is divided by the total number of mapped reads, Gene A has the same level of expression in Conditions 1 and 2. (B) In this example, Gene A is 4 times as
long but half as highly expressed as Gene B (20 vs. 5 in length; 1/cell vs. 2/cell in mRNAs), and Gene A gives twice as many RNA-seq reads as Gene B. If the
number of reads is divided by the length of a gene, the expression of Gene A is half as high as that of Gene B, consistent with the actual number of mRNAs in
a cell. (C) Examples shown in (A) and (B) demonstrate that the number of reads mapping to a gene needs to be normalized against the total number of
mapped reads (depth of the sequencing) and the length of the gene (the number of nucleotides in the exons of the gene). This leads to the deﬁnition of
RPKM. (D) The axial distribution of tubule markers along the nephron demonstrates that the gene expression as measured by RNA-seq is generally
consistent with prior knowledge of marker distribution (adapted from Lee et al [7]).
CCD, cortical collecting duct; CNT, connecting tubule; cTAL, cortical thick ascending limb; DCT, distal convoluted tubule; IMCD, inner medullary collecting
duct; LDLIM, long descending limb inner medulla; LDLOM, long descending limb outer medulla; mRNA, messenger RNA; mTAL, medullary thick ascending
limb; OMCD, outer medullary collecting duct; RNA-seq, RNA sequencing; RPKM, reads per kilobase exon models in million mapped reads; S1, S1 proximal
tubule; S2, S2 proximal tubule; S3, S3 proximal tubule; SDL, short descending limb; tAL, thin ascending limb.
Kidney Res Clin Pract 34 (2015) 219e227226renal tubule segments and plotted in line graphs, the axial dis-
tribution of tubule markers along the nephron was highly
consistent with our prior knowledge of their distribution,
demonstrating theprecisionofmanualmicrodissection (Fig. 6D)
[7].
When gene expression is compared between 2 conditions
(e.g., control vs. treatment, normal vs. disease), a more robust
statistical approach is used to model the raw count data into a
statistical model for discrete data. Initial efforts to model RNA-
seq data have been focused on the Poisson distribution [18].
Later, itwas found that RNA-seq data have larger variability than
that predicted by the Poisson distribution and that amodelwith
increased variability (i.e., negative binomial distribution) is
better at explaining RNA-seq data. For more information,
readers are referred to articles and instruction manuals for in-
dividual software packages that normalize and analyze differ-
ential expression in RNA-seq using a negative binomial model
(e.g., edgeR [19], DESeq [20], and DESeq2 [21]). As RNA-seq ex-
periments begin to involvemore replicates thanwerepreviously
available and amore complicated experimental design begins to
be applied, new analysis methods such as factor analysis [22]
and surrogate variable analysis [23] are emerging.Summary and future directions
This technical note introduced readers to RNA-seq of
microdissected renal tubule segments, focusing on how to
combine classical microdissection and a modiﬁed single-cell
RNA-seq protocol. The data generated from this work are
available both as supplemental data and a Web page (https://
helixweb.nih.gov/ESBL/Database/NephronRNAseq/), allowing
researchers to examine the expression of genes they are
interested in. The raw FASTQ sequences obtained from 105
samples of glomeruli and renal tubule segments are available at
Gene Expression Omnibus (GSE56743, http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc¼GSE56743).
Although tubule-level transcriptome data will continue to
generate new insights into the functions of the nephron, the
transcriptomic research in nephrology will eventually advance
to a single-cell level in the near future. Recent technical ad-
vances have made it possible for scientists to proﬁle single-cell
transcriptomes and reveal heterogeneous and stochastic nature
of gene expression in individual cells [24e26]. Furthermore,
single-cell RNA-seq has been used for marker-free decompo-
sition of tissues into cell types, thereby allowing researchers to
Lee / RNA sequencing of the nephron transcriptome 227identify a new cell type without prior knowledge of cell
markers [26,27]. The author believes that these advances ach-
ieved in single-cell biology of other cells and organs can be
reproduced in kidney research.
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